Immutep Competitors and Similar CompaniesClear all
Numab's competitors and similar companies include Acrivon.
 Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | ||
Founding Date | Founding Date 2011 | Founding Date 2018 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Wädenswil, CH HQ | Locations Watertown, US HQ Lund, SE |
Employees | Employees 681% decrease | Employees 415% increase |
For sources of this data, please see the company profile
View Company Profiles
Acrivon
HQ
Watertown, US
Employees
41↑ 5% increase
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company